Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1984.
Parkinson's Disease, 1984.
The Lancet,
Vol. 323,
Issue. 8381,
p.
829.
Gupta, M.
Felten, D.L.
and
Gash, D.M.
1984.
MPTP alters central catecholamine neurons in addition to the nigrostriatal system.
Brain Research Bulletin,
Vol. 13,
Issue. 6,
p.
737.
Jenner, Peter
Rupniak, Nadia M.J.
Rose, Sarah
Kelly, Eamonn
Kilpatrick, Gavin
Lees, Andrew
and
Marsden, C.David
1984.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
Neuroscience Letters,
Vol. 50,
Issue. 1-3,
p.
85.
Kelner, L.
Markey, S.P.
Fales, H.M.
and
Lundquist, T.R.
1984.
Secondary emission mass spectrometer, application and evaluation.
International Journal of Mass Spectrometry and Ion Processes,
Vol. 62,
Issue. 3,
p.
237.
Mytilineou, Catherine
and
Cohen, Gerald
1984.
1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Destroys Dopamine Neurons in Explants of Rat Embryo Mesencephalon.
Science,
Vol. 225,
Issue. 4661,
p.
529.
Parsons, Bruce
and
Rainbow, Thomas C.
1984.
High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase.
European Journal of Pharmacology,
Vol. 102,
Issue. 2,
p.
375.
Williams, A
1984.
MPTP parkinsonism..
BMJ,
Vol. 289,
Issue. 6456,
p.
1401.
Sirinathsinghji, Dalip J.S.
1985.
Intrahypothalamic infusions of a synthetic heroin substitute, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, potentiate mating behaviour in the female rat.
Brain Research,
Vol. 346,
Issue. 1,
p.
130.
Chiueh, C.C.
Burns, R.S.
Markey, S.P.
Jacobowitz, D.M.
and
Kopin, I.J.
1985.
III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
Life Sciences,
Vol. 36,
Issue. 3,
p.
213.
Gash, Don Marshall
Collier, Timothy J.
and
Sladek, John R.
1985.
Neural transplantation: A review of recent developments and potential applications to the aged brain.
Neurobiology of Aging,
Vol. 6,
Issue. 2,
p.
131.
Perry, Thomas L.
Wee Yong, Voon
Ito, Masatoshi
Jones, Karen
Wall, Richard A.
Foulks, James G.
Wright, James M.
and
Kish, Stephen J.
1985.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig.
Life Sciences,
Vol. 36,
Issue. 13,
p.
1233.
Sirinathsinghji, D.J.S.
1985.
Behavioural effects in the rat after acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Brain Research,
Vol. 339,
Issue. 2,
p.
366.
Fine, Alan
Reynolds, Gavin P.
Nakajima, Nobue
Jenner, Peter
and
Marsden, C.David
1985.
Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset.
Neuroscience Letters,
Vol. 58,
Issue. 1,
p.
123.
Bradbury, A.J.
Costall, B.
Domeney, A.M.
Testa, B.
Jenner, P.G.
Marsden, C.D.
and
Naylor, R.J.
1985.
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Neuroscience Letters,
Vol. 61,
Issue. 1-2,
p.
121.
Del Zompo, M.
Pintus, S.
Zuddas, A.
and
Corsini, G.U.
1985.
Deprenyl selectively inhibits [3H]MPTP binding sites in monkey brain.
European Journal of Pharmacology,
Vol. 107,
Issue. 2,
p.
285.
Schwartzman, Robert Jay
and
Alexander, Guillermo M.
1985.
Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
Brain Research,
Vol. 358,
Issue. 1-2,
p.
137.
Bradbury, A.J.
Costall, B.
Jenner, P.G.
Kelly, M.E.
Marsden, C.D.
and
Naylor, R.J.
1985.
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
Neuroscience Letters,
Vol. 58,
Issue. 2,
p.
177.
Barbeau, A.
Dallaire, L.
Buu, N.T.
Veilleux, F.
Boyer, H.
de Lanney, L.E.
Irwin, I.
Langston, E.B.
and
Langston, J.W.
1985.
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Life Sciences,
Vol. 36,
Issue. 11,
p.
1125.
Eidelberg, E.
Brooks, B.A.
Morgan, W.W.
Walden, J.G.
and
Kokemoor, R.H.
1986.
Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.
Neuroscience,
Vol. 18,
Issue. 4,
p.
817.
Markey, S. P.
and
Schmuff, N. R.
1986.
The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1–methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine) and structurally related compounds.
Medicinal Research Reviews,
Vol. 6,
Issue. 4,
p.
389.